Led by Santé, the funding will support completion of the world's first randomized HIFU trial for pancreatic cancer, and accelerate U.S. clinical programs for the company's anesthesia-free, outpatient ...
Sonire said the Series A funds will allow it to complete the randomised control trial of its high-intensity focused ...
Pharma Finance Roundup: Platform Innovation Drives Biotech Investment Across Oncology and Immunology
Launch financing of $300M enables Beeline to operationalize an in-licensed immunology portfolio, with afimetoran (TLR7/8) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results